About this trial
The purpose of this observational research is to evaluate and compare the health-related quality of life and emotional well-being of patients with thyroid nodules before and after treatment. This is a data collection study by allowing investigators to access information generated before and after treatment.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Clinical diagnosis of benign thyroid nodules or papillary thyroid carcinoma ;
underwent microwave ablation or thyroidectomy;
ability to understand and cooperate with the survey
Disqualifiers
serious primary diseases in the liver, kidney, hematopoietic, or endocrine systems;
a history of mental illness, personality disorders, cognitive impairments, or organic brain disease
Trial population
patients with thyroid nodules before and after treatments
Trial design
Cohort
Prospective
Treatments tested in this trial
thermal ablation
Procedure/Surgerythermal ablation including microwave ablation, radiofrequency ablation of thyroid nodules
thyroidectomy
Procedure/Surgerysurgical resection of thyroid nodules
Treatment groups
Trial outcomes
Primary outcomes
The Thyroid Cancer-Specific Quality of Life Questionnaire to assess the thyroid-specific quality of life
The Thyroid Cancer-Specific Quality of Life Questionnaire (THYCA-QoL), as a methodologically developed questionnaire, was used to assess thyroid-specific symptoms in thyroid cancer survivors. The questionnaire consists of seven symptom scales (neuromuscular, voice, concentration, sympathetic, throat/mouth, psychological and sensory problems) and six single items (problems with scar, felt chilly, tingling hands/feet, gained weight, headache, less interest in sex), with a time frame of the previous week (except for less interest in sex item, which is four weeks), and each item is scored on a four-point response scale ranging from 1, "not at all", to 4, "very much". Scores were linearly transformed to a 0-100 scale. A higher score on this scale means more symptoms and complaints.
the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire to assess the general quality of life
The European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30) was adopted as a valid measurement of quality of life for cancer patients. It consists of 5 functional scales , 3 symptom scales, 6 single-item common symptom, and global health status (GHS) subscales. The time frame of the questions is the previous week, and each item is scored on a four-point response scale ranging from 1 to 4, except the global status scale, which is scored on a seven-point modified linear analog scale ranging from 1, "very poor" to 7, "excellent". After linear transformation, all scales and single item measures range in score from 0-100. A higher score on the functional scales and global status scale means a better level of functioning and HRQoL, whereas a a higher score on the symptom scales and single item corresponds to more discomfort and complaints.
Hospital Anxiety and Depression Scale to assess the emotional status
The Hospital Anxiety and Depression Scale consists of 14 items measuring symptom severity on a scale of 0-3 with subscales for anxiety (HADS\_A) and depression (HADS\_D), and a range of possible scores for each subscale of 0-21. Cut-off scores of 8+ for both subscales demonstrate the optimal balance between sensitivity and specificity for identifying cases of anxiety disorders and depression, with sensitivity and specificity of approximately .8 for both subscales.
The functional assessment of chronic illness therapy-spiritual well-being questionnaire to assess spiritual well-being
The functional assessment of chronic illness therapy-spiritual well-being scale consists of 12 items formatted in a five-point Likert scale ranging from 0 = not at all to 4 = very much, with the exception of two negatively stated items (4 and 8) coded in a reverse manner. The responses to the self-reported items refer to a 7-day recall period. The scores are added to generate a total score ranging from 0 to 48. With the highest scores representing better spiritual wellbeing.
Secondary outcomes
serum thyroid hormone
changes in serum thyroid hormone
Percent Volume Changes of Nodules
Percent Volume Changes of Nodules: ((Volume (baseline)- Volume (\*m\*))/Volume (baseline))\*100
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Ming-an Yu
Lead sponsor
China-Japan Friendship Hospital
Sponsor institution